IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAVAZZANA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.434
EU - Europa 7.059
AS - Asia 4.509
SA - Sud America 947
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 22.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.281
IT - Italia 3.869
SG - Singapore 1.580
CN - Cina 1.556
UA - Ucraina 928
BR - Brasile 816
DE - Germania 610
HK - Hong Kong 499
FI - Finlandia 300
GB - Regno Unito 290
VN - Vietnam 279
FR - Francia 236
IE - Irlanda 227
RU - Federazione Russa 219
TR - Turchia 181
IN - India 125
CA - Canada 81
BD - Bangladesh 69
SE - Svezia 59
AR - Argentina 57
NL - Olanda 53
ZA - Sudafrica 40
AT - Austria 39
MX - Messico 39
ES - Italia 37
IQ - Iraq 34
PL - Polonia 31
JP - Giappone 30
BE - Belgio 27
EE - Estonia 23
ID - Indonesia 21
EC - Ecuador 20
RO - Romania 20
LT - Lituania 18
MA - Marocco 17
PK - Pakistan 17
AE - Emirati Arabi Uniti 15
SA - Arabia Saudita 14
JO - Giordania 13
VE - Venezuela 13
CH - Svizzera 12
EG - Egitto 12
KE - Kenya 12
UZ - Uzbekistan 12
KZ - Kazakistan 11
IL - Israele 10
PY - Paraguay 10
EU - Europa 9
AU - Australia 8
CZ - Repubblica Ceca 8
CO - Colombia 7
MK - Macedonia 7
UY - Uruguay 7
AZ - Azerbaigian 6
CL - Cile 6
LU - Lussemburgo 6
PA - Panama 6
PE - Perù 6
TT - Trinidad e Tobago 6
IR - Iran 5
JM - Giamaica 5
KG - Kirghizistan 5
AL - Albania 4
GR - Grecia 4
HN - Honduras 4
LV - Lettonia 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LI - Liechtenstein 3
MU - Mauritius 3
PH - Filippine 3
PT - Portogallo 3
SI - Slovenia 3
TN - Tunisia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
KR - Corea 2
LK - Sri Lanka 2
NP - Nepal 2
PS - Palestinian Territory 2
TH - Thailandia 2
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GY - Guiana 1
Totale 22.048
Salva come PNG Salva come JPEG
Città #
Fairfield 1.061
Woodbridge 800
Ashburn 723
Singapore 688
Jacksonville 680
Houston 576
Hong Kong 498
Beijing 424
Seattle 423
Cambridge 418
Wilmington 415
Ann Arbor 377
Princeton 310
Milan 283
Chandler 280
Los Angeles 251
New York 242
Nanjing 224
Chicago 208
Rome 197
Helsinki 177
Dublin 165
Istanbul 146
Brescia 124
Florence 104
Dallas 101
Ho Chi Minh City 100
The Dalles 95
Buffalo 94
Munich 91
Moscow 88
Des Moines 87
Nanchang 84
Salt Lake City 82
San Diego 67
São Paulo 65
Hebei 64
Redondo Beach 64
Shenyang 60
Turin 60
San Francisco 58
Lancaster 57
Hanoi 55
Trieste 55
Verona 55
Changsha 53
Tianjin 49
Bologna 46
Jinan 43
London 43
Shanghai 43
Jiaxing 39
Genoa 37
Dearborn 35
Elk Grove Village 34
Udine 34
Tampa 33
Brooklyn 32
Padova 32
Turku 30
Tokyo 29
Toronto 28
Brussels 27
Rio de Janeiro 26
Nuremberg 25
Phoenix 25
Genova 24
Kunming 24
Mumbai 24
Pisa 24
Santa Clara 23
Tallinn 23
Bergamo 22
Belo Horizonte 21
Modena 21
Syracuse 21
Hangzhou 20
Johannesburg 20
Menlo Park 20
Vienna 20
Falkenstein 19
Warsaw 19
Atlanta 18
Guangzhou 18
Ningbo 18
Reggio Nell'emilia 18
Chennai 17
Montreal 17
Torino 17
Miami 16
Naples 16
Redwood City 16
Trento 16
Bari 15
Frankfurt am Main 15
Palermo 15
Dhaka 14
Taizhou 14
Zhengzhou 14
Amman 13
Totale 12.651
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.330
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.758
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 683
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 198
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 192
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 183
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 174
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 167
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 165
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 163
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 163
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 161
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 154
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 153
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 153
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 153
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 152
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 151
Autoimmune polyendocrine Syndromes 149
The clinico-serological spectrum of overlap myositis 149
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 148
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 148
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 144
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 143
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 142
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 141
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 139
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 139
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 138
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 132
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 131
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 131
Renal Involvement in Primary Antiphospholipid Syndrome: Retrospective Analysis of 160 Patients. 130
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 129
Endothelium and the brain in CNS lupus. 129
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 129
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 127
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 127
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 127
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 126
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 126
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 125
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 125
Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? 125
Anti-Ro/SSA and La/SSB antibodies 124
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 123
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 121
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 119
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 118
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 118
Complement Activation and Pregnancy Failure. 116
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 116
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 114
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 114
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 114
Autoantibodies and Skin Involvement in Systemic Autoimmune Diseases 113
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 113
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 113
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 112
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 112
Update on Antiphospholipid Syndrome: Ten Topics in 2017 112
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 111
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 111
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 110
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 110
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 109
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 109
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 109
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 109
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 108
Cardiological features in idiopathic inflammatory myopathies. 108
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 108
Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations 108
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 108
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 108
Serologic profile and mortality rates of scleroderma renal crisis in Italy 107
Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety 106
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 106
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 106
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 105
Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block. 104
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 104
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 103
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 103
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 103
CLINICAL AND IMMUNOLOGICAL ASSOCIATION WITH AUTOANTIBODIES TO CELLULAR ANTIGEN IN A COHORT OF 532 SLE PATIENTS FROM A SINGLE CENTER 102
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 102
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 102
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 101
Ten Year Risk of Cardiovascular Events during anti-TNF Alpha in Rheumatoid Arthritis Patients 101
Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous. 101
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 99
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 99
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 99
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 98
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 98
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 97
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 97
Comparison of early and late onset systemic lupus erythematosus 95
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 94
Totale 16.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.251
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.678 0 0 0 0 0 281 119 271 312 286 281 128
2021/20221.997 113 248 112 106 116 147 151 154 135 195 180 340
2022/20231.482 207 26 45 64 115 331 36 164 257 50 102 85
2023/20241.543 81 52 120 121 86 278 82 68 330 58 62 205
2024/20254.119 70 75 59 366 368 358 262 159 354 317 853 878
2025/20263.756 632 976 510 925 631 82 0 0 0 0 0 0
Totale 22.355